prometheus biosciences, inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases.
Company profile
Ticker
RXDX
Exchange
Website
CEO
Mark C. McKenna
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Precision IBD, Inc.
SEC CIK
Corporate docs
IRS number
814282653
RXDX stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
27 Jun 23
25-NSE
Exchange delisting
16 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 23
POSASR
Automatic shelf registration (post-effective amendment)
16 Jun 23
8-K
Completion of Acquisition or Disposition of Assets
16 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
DEFA14A
Additional proxy soliciting materials
6 Jun 23
DEFA14A
Additional proxy soliciting materials
23 May 23
8-K
Other Events
23 May 23
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 113.35 mm | 113.35 mm | 113.35 mm | 113.35 mm | 113.35 mm | 113.35 mm |
Cash burn (monthly) | 59.69 mm | 9.47 mm | 16.23 mm | 13.53 mm | 13.18 mm | 11.12 mm |
Cash used (since last report) | 763.30 mm | 121.15 mm | 207.60 mm | 173.04 mm | 168.55 mm | 142.16 mm |
Cash remaining | -649.95 mm | -7.80 mm | -94.25 mm | -59.69 mm | -55.21 mm | -28.82 mm |
Runway (months of cash) | -10.9 | -0.8 | -5.8 | -4.4 | -4.2 | -2.6 |
Institutional ownership, Q2 2023
16.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 1 |
Closed positions | 216 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 147.52 mm |
Total shares | 7.73 mm |
Total puts | 279.60 k |
Total calls | 74.50 k |
Total put/call ratio | 3.8 |
Largest owners | Shares | Value |
---|---|---|
Cedars Sinai Intellectual Property | 4.00 mm | $0.00 |
Nestle Health Science US | 3.73 mm | $147.52 mm |
Simplex Trading | 0.00 | $0.00 |
Maven Securities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jun 23 | Fred Hassan | Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,123 | 0.00 | 0 |
16 Jun 23 | Fred Hassan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 29.02 | 21,013 | 609.80 k | 0 |
16 Jun 23 | Fred Hassan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 36.32 | 541 | 19.65 k | 0 |
16 Jun 23 | Fred Hassan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.82 | 40,000 | 672.80 k | 0 |
16 Jun 23 | Marshall Keith W | Common Stock | Sale back to company | Dispose D | No | No | 0 | 87,973 | 0.00 | 0 |
16 Jun 23 | Marshall Keith W | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 108.76 | 12,920 | 1.41 mm | 0 |
16 Jun 23 | Marshall Keith W | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 110.2 | 34,085 | 3.76 mm | 0 |
16 Jun 23 | Marshall Keith W | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 29.56 | 86,582 | 2.56 mm | 0 |
16 Jun 23 | Marshall Keith W | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 36.32 | 102,155 | 3.71 mm | 0 |
16 Jun 23 | Marshall Keith W | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.7 | 135,913 | 910.62 k | 0 |